Evonik Industries AG (ETR:EVK)
16.03
-0.05 (-0.31%)
Jun 22, 2026, 5:35 PM CET
Evonik Industries AG Revenue
Evonik Industries AG had revenue of 3.43B EUR in the quarter ending March 31, 2026, a decrease of -9.27%. This brings the company's revenue in the last twelve months to 13.72B, down -9.37% year-over-year. In the year 2025, Evonik Industries AG had annual revenue of 14.07B, down -7.18%.
Revenue (ttm)
13.72B
Revenue Growth
-9.37%
P/S Ratio
0.54
Revenue / Employee
447.70K
Employees
30,643
Market Cap
7.47B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 14.07B | -1.09B | -7.18% |
| Dec 31, 2024 | 15.16B | -110.00M | -0.72% |
| Dec 31, 2023 | 15.27B | -3.22B | -17.42% |
| Dec 31, 2022 | 18.49B | 3.53B | 23.62% |
| Dec 31, 2021 | 14.96B | 2.76B | 22.59% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Brenntag SE | 14.76B |
| Covestro AG | 12.94B |
| LANXESS Aktiengesellschaft | 5.45B |
| Wacker Chemie AG | 5.41B |
| Symrise AG | 4.93B |
| Fuchs SE | 3.57B |
| Verbio SE | 1.78B |
| H&R GmbH & Co. KGaA | 1.21B |
Evonik Industries AG News
- 3 days ago - Evonik price target raised to EUR 17 from EUR 16 at Deutsche Bank - TheFly
- 12 days ago - Evonik Industries AG Transcript: Investor update - Transcripts
- 14 days ago - Evonik downgraded to Neutral from Buy at Goldman Sachs - TheFly
- 17 days ago - Evonik price target raised to EUR 20 from EUR 17 at Citi - TheFly
- 19 days ago - Evonik Industries AG Transcript: AGM 2026 - Transcripts
- 4 weeks ago - Evonik downgraded to Underweight from Neutral at JPMorgan - TheFly
- 4 weeks ago - Evonik downgraded to Equal Weight from Overweight at Barclays - TheFly
- 4 weeks ago - Evonik upgraded to Buy from Hold at Jefferies - TheFly